1. Indications and Usage for Paxlovid PAXLOVID is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. Limitations of Use PAXLOVID is not approved for use ...
While data forhealthy adultsshow the drug makes no meaningful difference, it shows significant benefits for high-risk adults. Paxlovid reduces the chance of hospitalization and death by about 60 to 85 percent for seniors and adults who havehealth issuesthat include obesity, diabetes,lung disease, ...
当地时间12月28日,《新英格兰医学杂志》(NEJM)发表了VV116头对头比较Paxlovid用于治疗高危、轻-中度新冠患者的非劣效3期试验,结果显示在至临床恢复时间方面达到非劣效性,且VV116的不良事件更少[1]。该研究由上海瑞金医院赵任教授、上...
Similarly, the antiviralmolnupiravir(Lagevrio), whichreceived an EUAin December 2021 for treating mild to moderate COVID-19 in high-risk adults aged 18 years or older, is taken as a pill for 5 days, starting within 5 days of symptom onset. However, when compared with a placebo in the ...